Summary
Bosnalijek dd (Bosnalijek) manufactures and markets food supplements. The company develops, manufactures and exports medicines, disinfectants for domestic use, disinfectants, and medical use. Its product portfolio includes amoxicillin, diclofenac potassium, B complex vitamins, ephedrine, sulpiride, fluoxetine, torasemide, valsartan, paracetamol, and others. Bosnalijek manufactures products in various formulations which include ampoules, tablets, film-coated tablets, capsules, balms, gels, emulsions, suspensions and syrups. The company offers products in the areas of digestive system and metabolism, cardiovascular system, systemic infections, skin, skeletomuscular, nervous and respiratory system. It operates through representative offices located in different parts of the world. Bosnalijek is headquartered in Sarajevo, Bosnia and Herzegovina.
Bosnalijek dd (BSNLR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Bosnalijek dd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bosnalijek dd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bosnalijek dd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bosnalijek dd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Bosnalijek dd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Bosnalijek dd, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Abdi Ibrahim Enters into Licensing Agreement with Bosnalijek 10
Acquisition 10
Government of Bosnia-Herzegovina to Sell 19% Stake in Bosnalijek for USD13 Million 10
Haden Acquires Additional Stake In Bosnalijek 11
Bosnalijek dd - Key Competitors 13
Key Employees 14
Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16
List of Tables
Bosnalijek dd, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Bosnalijek dd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bosnalijek dd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bosnalijek dd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bosnalijek dd, Deals By Therapy Area, 2011 to YTD 2017 8
Bosnalijek dd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Abdi Ibrahim Enters into Licensing Agreement with Bosnalijek 10
Government of Bosnia-Herzegovina to Sell 19% Stake in Bosnalijek for USD13 Million 10
Haden Acquires Additional Stake In Bosnalijek 11
Bosnalijek dd, Key Competitors 13
Bosnalijek dd, Key Employees 14
List of Figures
Bosnalijek dd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Bosnalijek dd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Bosnalijek dd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Bosnalijek dd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Bosnalijek dd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bosnalijek dd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Bosnalijek dd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bosnalijek dd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8